➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
Dow
Medtronic
Colorcon
Express Scripts

Last Updated: July 6, 2020

DrugPatentWatch Database Preview

MAGNESIUM SULFATE IN PLASTIC CONTAINER Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

When do Magnesium Sulfate In Plastic Container patents expire, and what generic alternatives are available?

Magnesium Sulfate In Plastic Container is a drug marketed by Baxter Hlthcare Corp, Fresenius Kabi Usa, Hospira, Hq Spclt Pharma, and Mylan Labs Ltd. and is included in five NDAs.

The generic ingredient in MAGNESIUM SULFATE IN PLASTIC CONTAINER is magnesium sulfate. There are one hundred and forty-six drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the magnesium sulfate profile page.

US ANDA Litigation and Generic Entry Outlook for Magnesium Sulfate In Plastic Container

A generic version of MAGNESIUM SULFATE IN PLASTIC CONTAINER was approved as magnesium sulfate by FRESENIUS KABI USA on September 8th, 1986.

  Start Trial

Drug patent expirations by year for MAGNESIUM SULFATE IN PLASTIC CONTAINER
Recent Clinical Trials for MAGNESIUM SULFATE IN PLASTIC CONTAINER

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Wright State UniversityPhase 4
Kasr El Aini HospitalN/A
Dalia Saad Abd-El KaderPhase 4

See all MAGNESIUM SULFATE IN PLASTIC CONTAINER clinical trials

US Patents and Regulatory Information for MAGNESIUM SULFATE IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare Corp MAGNESIUM SULFATE IN PLASTIC CONTAINER magnesium sulfate INJECTABLE;INJECTION 211966-001 Jun 1, 2020 AP RX No No   Start Trial   Start Trial   Start Trial
Hq Spclt Pharma MAGNESIUM SULFATE IN PLASTIC CONTAINER magnesium sulfate INJECTABLE;INJECTION 207350-005 Dec 6, 2017 AP RX No No   Start Trial   Start Trial   Start Trial
Fresenius Kabi Usa MAGNESIUM SULFATE IN PLASTIC CONTAINER magnesium sulfate INJECTABLE;INJECTION 206485-005 Mar 15, 2016 AP RX No No   Start Trial   Start Trial   Start Trial
Fresenius Kabi Usa MAGNESIUM SULFATE IN PLASTIC CONTAINER magnesium sulfate INJECTABLE;INJECTION 206485-003 Mar 15, 2016 AP RX No No   Start Trial   Start Trial   Start Trial
Hospira MAGNESIUM SULFATE IN PLASTIC CONTAINER magnesium sulfate INJECTABLE;INJECTION 020309-004 Jan 18, 1995 AP RX Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
Dow
Medtronic
Colorcon
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.